Rasio rega marang bathi Alpha Cognition Inc. (ACOG)
High patent barriers and stringent FDA safety requirements provide significant protection for Alpha Cognition (ACOG) developments in the field of cognitive disorders. The accuracy of therapy data is guaranteed by strict controls during the transport of biomaterials. This chart on GURU.Markets shows that the P/E ratio is -8.10. The business model relies on R&D and production outsourcing, fully delegating drug manufacturing to external contractors.
Rincian analitis perusahaan Alpha Cognition Inc (ACOG)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Alpha Cognition|ACOG - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Alpha Cognition Corp|ACOG - Gunggung utang perusahaan|Utang marang nilai buku Alpha Cognition Inc.|ACOG - Utang jangka dawa perusahaan|Utang jangka cendhak Alpha Cognition|Likuiditas kritis alphacognition.com
- indikator pendapatan resik lan kelipatan nilai:
ACOG - Bathi resik perusahaan|Prakiraan bathi resik Alpha Cognition|ACOG - Pangali P/E|Kapitalisasi marang proyeksi bathi Alpha Cognition Corp|ACOG - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Alpha Cognition Inc.|ACOG - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Alpha Cognition|ACOG - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan alphacognition.com|ACOG - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Alpha Cognition
Ringkesan analisis perusahaan:ACOG alphacognition.com
For Alpha Cognition, a developer of Alzheimer's disease therapies, the P/E ratio serves as an indicator of market expectations regarding future earnings. This metric is calculated as the ratio of market capitalization to net income, determining the cost of one dollar of earnings. By analyzing the price-to-earnings trend, an investor assesses the degree of the asset's overvaluation. In this instance, the indicator reflects the market's speculative bet on the successful FDA approval of the Alpha-1062 molecule.
Analisis perusahaan pesaing
Pangali P/E biogen.com|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|Rasio rega marang bathi RGC (Regencell Bioscience Ltd)|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|ACAD (ACADIA Corp) - Kapitalisasi marang bathi resik|Xenon Pharmaceuticals - Pangali P/E|Nilai perusahaan marang bathi resik VKTX (vikingtherapeutics.com)|SUPN: Pangali P/E|Catalyst Pharma (CPRX) - Pangali P/E|Koefisien rega marang bathi DNLI|HRMY: Nilai perusahaan marang bathi resik|Pangali P/E BHVN|Koefisien rega marang bathi amylyx.com AMLX|Rasio rega marang bathi Trevi Therapeutics, Inc. TRVI|Praxis Precision Medicines Inc (PRAX) - Kapitalisasi marang bathi|Anavex Corp - Pangali P/E|Rasio kapitalisasi marang bathi resik CeriBell EEG (CBLL)|prothena.com (PRTA) - Rasio rega marang bathi|Pangali rega marang bathi ALEC|ANNX (Annexon) - Pangali P/E|Omeros Corp. (OMER) - Periode bali modal bisnis|Koefisien rega marang bathi NGNE (Neurogene Corp)|Rasio rega pasar marang bathi resik ACIU|Pangali P/E VYGR (Voyager Therapeutics)|Periode bali modal bisnis neumoratx.com (NMRA)|SCLX - Rasio rega marang bathi|Kapitalisasi marang bathi Tevogen Bio Holdings Inc.|Cognition Therapeutics, Inc. (CGTX) - Rasio rega marang bathi|Pangali rega marang bathi IKT|SAVA (Cassava Sciences, Inc.) - Pangali P/E|Pangali P/E Assertio Therapeutics|Pangali P/E COYA|Koefisien rega marang bathi vistagen.com VTGN|Rasio rega marang bathi Ovid Therapeutics OVID|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalisasi marang bathi|CervoMed Inc. - Pangali P/E|Rasio kapitalisasi marang bathi resik Alterity Therapeutics (ATHE)|clene.com (CLNN) - Rasio rega marang bathi|Pangali rega marang bathi PEPG|JUNS (Jupiter Neurosciences) - Pangali P/E|Kapitalisasi marang bathi Relmada Corp RLMD|Koefisien rega marang bathi ANVS (Annovis Bio, Inc.)|Pangali P/E gracetx.com (GRCE)|Rasio rega marang bathi Firefly Neuroscience AIFF|Nilai perusahaan marang bathi resik KLTO|NRSN - Rasio rega marang bathi|Kapitalisasi marang bathi Reviva Pharmaceuticals, Inc.|MTVA: Pangali P/E|neuraxis.com (NRXS) - Pangali P/E|Rasio rega marang bathi Helius Medical Technologies, Inc.|Rasio rega marang bathi PASG|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|NERV: Kapitalisasi marang bathi resik|Pangali P/E ATHA (Athira Pharma, Inc.)|Nilai perusahaan marang bathi resik ADXN|Alzamend - Pangali P/E|CYCN - Pangali P/E|PTIX (protagenic.com) - Koefisien rega marang bathi|Pasithea Therapeutics Corp. - Nilai perusahaan marang bathi resik|CRGT (Cortigent Inc) - Pangali P/E|Koefisien rega marang bathi avenuetx.com (ATXI)|Rasio rega marang bathi BrainStorm Cell Therapeutics (BCLI)|CARA - Kapitalisasi marang bathi|Pangali P/E CHRO (Chromocell Therapeutics Corporation)|Rasio kapitalisasi marang bathi resik Eliem Therapeutics, Inc.|ITCI - Rasio rega marang bathi|LBPH (longboardpharma.com) - Pangali rega marang bathi|MRNS: Pangali P/E|NKGN - Periode bali modal bisnis|Koefisien rega marang bathi NRBO|SAGE (Sage Therapeutics Inc) - Rasio rega pasar marang bathi resik|Pangali P/E SNPX|Periode bali modal bisnis trevena.com|Rasio rega marang bathi Vigil Neuroscience, Inc. VIGL|anewmeds.com (WENA) - Kapitalisasi marang bathi|CERE - Rasio rega marang bathi
